latanoprost/dorzolamide (CKD-351)
/ Chong Kun Dang
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 27, 2022
Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease.
(PubMed, Pharmaceuticals (Basel))
- "No new safety concerns were observed. PF-tafluprost and PF-dorzolamide/timolol showed statistically and clinically significant reductions in OSDI compared with P-latanoprost in Korean glaucoma patients with OSD."
Clinical • Journal • Patient reported outcomes • Dry Eye Disease • Glaucoma • Ophthalmology
1 to 1
Of
1
Go to page
1